KIF20A and breast carcinoma: Ectopic expression of KIF20A promoted chemoresistance of CRC cells to oxaliplatin or 5-FU treatment by decreasing apoptosis 37 and also indicated that expression of KIF4A, KIF15, KIF20A and KIF23 was correlated with prognosis in breast cancer.